Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis

Objectives: The impressive improvements of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) function by elexacaftor/tezacaftor/ivacaftor (ETI) result in changes in the detection frequencies of Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA). We assessed determinants of the...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Anna-Maria Dittrich, Sarah Sieber, Lutz Naehrlich, Manuel Burkhart, Sylvia Hafkemeyer, Burkhard Tümmler
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2024-02-01
Serie:	International Journal of Infectious Diseases
Ämnen:	Cystic fibrosis Pseudomonas aeruginosa Staphylococcus aureus CFTR modulator Elexacaftor, tezacaftor, ivacaftor
Länkar:	http://www.sciencedirect.com/science/article/pii/S1201971223007749
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!